Discovery of new biomarkers for malignant mesothelioma

Por Creaney, Jenette, Dick, Ian M., Robinson, Bruce W. S.
Publicado no Curr Pulmonol Rep (2015)

Tumor Antigen Cross-Presentation and the Dendritic Cell: Where it All Begins?

Por McDonnell, Alison M., Robinson, Bruce W. S., Currie, Andrew J.
Publicado em 2010

A Proteomic Analysis of the Malignant Mesothelioma Secretome Using iTRAQ

Por CREANEY, JENETTE, DICK, IAN M, LEON, JUSTINE S, ROBINSON, BRUCE W.S
Publicado no Cancer Genomics Proteomics (2017)

Auto-Antibodies to β-F1-ATPase and Vimentin in Malignant Mesothelioma

Por Creaney, Jenette, Dick, Ian M., Yeoman, Deborah, Wong, Sarah, Robinson, Bruce W. S.
Publicado em 2011

Chemotherapy Enhances Cross-Presentation of Nuclear Tumor Antigens

Por Anyaegbu, Chidozie C., Lake, Richard A., Heel, Kathy, Robinson, Bruce W., Fisher, Scott A.
Publicado em 2014

Programmed Death Ligand 2 in Cancer-Induced Immune Suppression

Por Rozali, Esdy N., Hato, Stanleyson V., Robinson, Bruce W., Lake, Richard A., Lesterhuis, W. Joost
Publicado em 2012

Association of Biomarker Levels with Severity of Asbestos-Related Diseases

Por Park, Eun-Kee, Yates, Deborah H, Creaney, Jenette, Thomas, Paul S, Robinson, Bruce W, Johnson, Anthony R
Publicado em 2012

Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo

Por Greening, David W., Ji, Hong, Chen, Maoshan, Robinson, Bruce W. S., Dick, Ian M., Creaney, Jenette, Simpson, Richard J.
Publicado no Sci Rep (2016)

Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma

Por Creaney, Jenette, Segal, Amanda, Olsen, Nola, Dick, Ian M., Musk, A. W(Bill), Skates, Steven J., Robinson, Bruce W.
Publicado no Dis Markers (2014)

ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms

Por Morré, D. James, Hostetler, Brandon, Taggart, David J., Morré, Dorothy M., Musk, A. W., Robinson, Bruce W. S., Creaney, Jenette
Publicado no Clin Proteomics (2016)

Erratum to: ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4–10 years in advance of clinical symptoms

Por Morré, D. James, Hostetler, Brandon, Taggart, David J., Morré, Dorothy M., Musk, A. W., Robinson, Bruce W. S., Creaney, Jenette
Publicado no Clin Proteomics (2016)

Tumor cells, rather than dendritic cells, deliver antigen to the lymph node for cross-presentation

Por McDonnell, Alison M., Currie, Andrew J., Brown, Matthew, Kania, Kasia, Wylie, Ben, Cleaver, Amanda, Lake, Richard, Robinson, Bruce W.S.
Publicado em 2012

Comparison of the Diagnostic Accuracy of the MSLN Gene Products, Mesothelin and Megakaryocyte Potentiating Factor, as Biomarkers for Mesothelioma in Pleural Effusions and Serum

Por Creaney, Jenette, Sneddon, Sophie, Dick, Ian M., Dare, Hanne, Boudville, Neil, Musk, Arthur William, Skates, Steven J., Robinson, Bruce W. S.
Publicado em 2013

Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma

Por Robinson, Cleo, Dick, Ian M., Wise, Michael J., Holloway, Andrew, Diyagama, Dileepa, Robinson, Bruce W. S., Creaney, Jenette, Lake, Richard A.
Publicado no BMC Cancer (2015)

Loss of antigen cross-presentation after complete tumor resection is associated with the generation of protective tumor-specific CD8(+) T-cell immunity

Por Brown, Matthew D., van der Most, Robbert, Vivian, Justin B., Lake, Richard A., Larma, Irma, Robinson, Bruce W. S., Currie, Andrew J.
Publicado em 2012

Statins Do Not Alter the Incidence of Mesothelioma in Asbestos Exposed Mice or Humans

Por Robinson, Cleo, Alfonso, Helman, Woo, Samantha, Walsh, Amy, Olsen, Nola, Musk, Arthur W., Robinson, Bruce W. S., Nowak, Anna K., Lake, Richard A.
Publicado em 2014

Synergistic Effect of CTLA-4 Blockade and Cancer Chemotherapy in the Induction of Anti-Tumor Immunity

Por Lesterhuis, W. Joost, Salmons, Joanne, Nowak, Anna K., Rozali, Esdy N., Khong, Andrea, Dick, Ian M., Harken, Julie A., Robinson, Bruce W., Lake, Richard A.
Publicado em 2013

Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations

Por Lesterhuis, W. Joost, Rinaldi, Catherine, Jones, Anya, Rozali, Esdy N., Dick, Ian M., Khong, Andrea, Boon, Louis, Robinson, Bruce W., Nowak, Anna K., Bosco, Anthony, Lake, Richard A.
Publicado no Sci Rep (2015)

The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40

Por Khong, Andrea, Cleaver, Amanda L, Fahmi Alatas, Muhammad, Wylie, Ben C, Connor, Theresa, Fisher, Scott A, Broomfield, Steve, Lesterhuis, Willem J, Currie, Andrew J, Lake, Richard A, Robinson, Bruce W
Publicado no BMC Cancer (2014)

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma

Por Creaney, Jenette, Dick, Ian M, Meniawy, Tarek M, Leong, Su Lyn, Leon, Justine S, Demelker, Yvonne, Segal, Amanda, (Bill) Musk, A W, Lee, Y C Gary, Skates, Steven J, Nowak, Anna K, Robinson, Bruce W S
Publicado em 2014